Search results
Author(s):
Abhishek Maan
,
Moussa Mansour
,
Jeremy N Ruskin
,
et al
Added:
3 years ago
Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice.1 It has been estimated that >3million people in the US and >4.5 million in the EU have paroxysmal or persistent AF.2–4 AF is associated with an approximately fivefold increased risk of stroke,5 threefold risk of heart failure,6 diminished quality of life7 and increased healthcare costs.8,9…
View more
Author(s):
Yaacoub Chahine
,
Matthew J Magoon
,
Bahetihazi Maidu
,
et al
Added:
1 year ago
Author(s):
Tolga Aksu
,
Jamario R Skeete
,
Henry H Huang
Added:
1 year ago
A Critical Reappraisal of the Current Clinical Indications to Cardiac Resynchronisation Therapy
Author(s):
Antonio Sorgente
,
Riccardo Cappato
Added:
3 years ago
Article
Author(s):
Nur A Rahmat
,
Gregory YH Lip
Added:
3 years ago
Until recently, the vitamin K antagonist (VKA, e.g. warfarin) class of drugs was the only oral anticoagulant in use. VKAs have important inter- and intra-patient variability, influenced by diet, alcohol and drugs; thus, regular anticoagulation monitoring is necessary. Indeed, VKAs offer their best efficacy and safety when the average time in therapeutic range (TTR) is >65–70 % in a particular…
View more
Author(s):
Sebastian Clauss
,
Moritz F Sinner
,
Stefan Kääb
,
et al
Added:
3 years ago
Atrial fibrillation (AF) is the most common arrhythmia experienced in clinical practice, and is responsible for significant morbidity and mortality.1 It affects more than 6 million people in Europe.1 The lifetime risk of developing AF after the age of 40 is approximately 25 %.1 AF is a major public health burden as it is associated with an increased risk of stroke by fivefold, dementia by twofold…
View more
Author(s):
Agnieszka Smoczynska
,
Henriëtte DM Beekman
,
Marc A Vos
Added:
3 years ago
The plasticity of the heart enables it to adapt to certain pathological insults and to maintain the cardiac output necessary to satisfy the metabolic requirements of the body.1 Although beneficial at first, this process of ventricular remodelling can have detrimental effects on cardiac function and contribute to arrhythmogenesis.2 Sudden cardiac death due to ventricular tachyarrhythmias accounts…
View more
Miracor Medical Systems GmbH
Supplier
Douglas L Mann
Job title: MD Washington University School of Medicine, St Louis, MO, US
Author
Author(s):
Dominik Linz
,
Sander Verheule
,
Aaron Isaacs
,
et al
Added:
2 years ago